“The European Commission’s Pharmaceutical Strategy: Implications for Intellectual Property Rights and Innovation in the Industry”

2023-04-23 07:32:37

This has to be the industry’s biggest overhaul for 20 years, and its announcement has already been delayed multiple times, tell it Financial Times. On Wednesday, the European Commission must present the axes of its new pharmaceutical strategy, expected since the pandemic; pharmaceutical companies fear that intellectual property rights will be reduced from 10 to 8 years and Germany followed by other smaller countries wrote a position paper warning that it would harm innovation if exclusivity periods were reduced, with generics that would arrive on the market more quickly.

1682235923
#Germany #concerned #pharmaceutical #strategy

Leave a Replay